Probiotics for Type 2 Diabetes

A study published in the British Medical Journal in 2020 showed a significant improvement in postprandial (after meal) glucose control in type 2 diabetics who took a probiotic containing the microbes Akkermansia muciniphila, Anaerobutyricum hallii, Clostridium beijerinckii, Clostridium butyricum, and Bifidobacterium infantis. The mean A1c or 3 month average glucose decreased by 0.6% over 12 weeks compared to placebo. Transient mild nausea and diarrhea occurred during the initial 3–5 days of use.

Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Research & Care. 2020;8:e001319. https://doi.org/10.1136/bmjdrc-2020-001319